Los Angeles based Capricor, Inc. is a biotechnology firm developing and optimizing powerful cardiac stem cell treatments to regenerate the heart. Capricor is the only stem cell company working to develop and commercialize cardiac stem cell therapies based on Cardiospheres, a proprietary mixture of three-dimensional cells from the heart itself.  Where other organizations derive stem cells to treat heart disease from sources such as adipose, embryonic or bone marrow tissue, Capricor’s work begins and ends with the heart.

Click to accept cookies and enable this content

Contact Capricor, Inc.
310-358-3200
info@capricor.com
Visit Website